121 related articles for article (PubMed ID: 19274717)
1. In vivo and in vitro characterization of poly(styrene-b-isobutylene-b-styrene) copolymer stent coatings for biostability, vascular compatibility and mechanical integrity.
Strickler F; Richard R; McFadden S; Lindquist J; Schwarz MC; Faust R; Wilson GJ; Boden M
J Biomed Mater Res A; 2010 Feb; 92(2):773-82. PubMed ID: 19274717
[TBL] [Abstract][Full Text] [Related]
2. Controlled delivery of paclitaxel from stent coatings using poly(hydroxystyrene-b-isobutylene-b-hydroxystyrene) and its acetylated derivative.
Sipos L; Som A; Faust R; Richard R; Schwarz M; Ranade S; Boden M; Chan K
Biomacromolecules; 2005; 6(5):2570-82. PubMed ID: 16153094
[TBL] [Abstract][Full Text] [Related]
3. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
Richard R; Schwarz M; Chan K; Teigen N; Boden M
J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
[TBL] [Abstract][Full Text] [Related]
4. Physical characterization of controlled release of paclitaxel from the TAXUS Express2 drug-eluting stent.
Ranade SV; Miller KM; Richard RE; Chan AK; Allen MJ; Helmus MN
J Biomed Mater Res A; 2004 Dec; 71(4):625-34. PubMed ID: 15514926
[TBL] [Abstract][Full Text] [Related]
5. Hemocompatibility of drug-eluting coronary stents coated with sulfonated poly (styrene-block-isobutylene-block-styrene).
Zhu JZ; Xiong XW; Du R; Jing YJ; Ying Y; Fan XM; Zhu TQ; Zhang RY
Biomaterials; 2012 Nov; 33(33):8204-12. PubMed ID: 22898183
[TBL] [Abstract][Full Text] [Related]
6. Styrenic block copolymers for biomaterial and drug delivery applications.
Ranade SV; Richard RE; Helmus MN
Acta Biomater; 2005 Jan; 1(1):137-44. PubMed ID: 16701787
[TBL] [Abstract][Full Text] [Related]
7. NMR characterization of paclitaxel/poly (styrene-isobutylene-styrene) formulations.
Chen JZ; Ranade SV; Xie XQ
Int J Pharm; 2005 Nov; 305(1-2):129-44. PubMed ID: 16207518
[TBL] [Abstract][Full Text] [Related]
8. Medical applications of poly(styrene-block-isobutylene-block-styrene) ("SIBS").
Pinchuk L; Wilson GJ; Barry JJ; Schoephoerster RT; Parel JM; Kennedy JP
Biomaterials; 2008 Feb; 29(4):448-60. PubMed ID: 17980425
[TBL] [Abstract][Full Text] [Related]
9. Application of coherent anti-Stokes Raman scattering microscopy to image the changes in a paclitaxel-poly(styrene-b-isobutylene-b-styrene) matrix pre- and post-drug elution.
Kang E; Wang H; Kwon IK; Song YH; Kamath K; Miller KM; Barry J; Cheng JX; Park K
J Biomed Mater Res A; 2008 Dec; 87(4):913-20. PubMed ID: 18228250
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stent coatings.
Puskas JE; Muñoz-Robledo LG; Hoerr RA; Foley J; Schmidt SP; Evancho-Chapman M; Dong J; Frethem C; Haugstad G
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):451-62. PubMed ID: 20049810
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, properties, and drug release of poly(alkyl methacrylate-b-isobutylene-b-alkyl methacrylate).
Cho JC; Cheng G; Feng D; Faust R; Richard R; Schwarz M; Chan K; Boden M
Biomacromolecules; 2006 Nov; 7(11):2997-3007. PubMed ID: 17096524
[TBL] [Abstract][Full Text] [Related]
12. A phospholipid-modified polystyrene-polyisobutylene-polystyrene (SIBS) triblock polymer for enhanced hemocompatibility and potential use in artificial heart valves.
Duraiswamy N; Choksi TD; Pinchuk L; Schoephoerster RT
J Biomater Appl; 2009 Jan; 23(4):367-79. PubMed ID: 18697881
[TBL] [Abstract][Full Text] [Related]
13. Parameter estimation methodology in a model of hydrophobic drug release from a polymer coating.
Sirianni RW; Jang EH; Miller KM; Saltzman WM
J Control Release; 2010 Mar; 142(3):474-82. PubMed ID: 19958804
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of acrylate-based block copolymers prepared by atom transfer radical polymerization as matrices for paclitaxel delivery from coronary stents.
Richard RE; Schwarz M; Ranade S; Chan AK; Matyjaszewski K; Sumerlin B
Biomacromolecules; 2005; 6(6):3410-8. PubMed ID: 16283773
[TBL] [Abstract][Full Text] [Related]
15. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
Thompson CA; Huibregtse B; Poff B; Wilson GJ
Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
17. Lipid-induced degradation in biocompatible poly(Styrene-Isobutylene-Styrene) (SIBS) thermoplastic elastomer.
Fittipaldi M; Grace LR
J Mech Behav Biomed Mater; 2017 Apr; 68():80-87. PubMed ID: 28157597
[TBL] [Abstract][Full Text] [Related]
18. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of the safety and stability of the TAXUS Paclitaxel-Eluting Coronary Stent.
Boden M; Richard R; Schwarz MC; Kangas S; Huibregtse B; Barry JJ
J Mater Sci Mater Med; 2009 Jul; 20(7):1553-62. PubMed ID: 19259791
[TBL] [Abstract][Full Text] [Related]
20. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
